Depression of NMDA receptor-mediated synaptic transmission by four α2 adrenoceptor agonists on the in vitro rat spinal cord preparation

British Journal of Pharmacology

Volumn 124, Issue 3, 1998, Pages 507-512

  Faber, E S L ^a   Chambers, J P ^a,b   Evans, R H ^a  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

2 adrenoceptor agonists; Detomidine; Dexmedetomidine; Romifidine; Spinal cord; Xylazine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATIPAMEZOLE; DETOMIDINE; DEXMEDETOMIDINE; IMIDAZOLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ROMIFIDINE; XYLAZINE;

ANALGESIC ACTIVITY; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DORSAL ROOT; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; MOTONEURON; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL REFLEX; SYNAPTIC TRANSMISSION; VENTRAL ROOT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANIMALS, NEWBORN; ELECTRIC STIMULATION; EVOKED POTENTIALS; NERVE FIBERS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, N-METHYL-D-ASPARTATE; REFLEX; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 0031747034     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701873     Document Type: Article

References (46)

1. AKAGI, H., KONISHI, S., OTSUKA, M. & YANAGISAWA, M. (1985). The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord. Br. J. Pharmacol., 84, 663-673.
2. BELCHER, G., RYALL, R.W. & SCHAFFNER, R. (1978). The differential effects of 5-hydroxytryptamine, noradrenaline and raphe stimulation on nociceptive and non-nociceptive dorsal horn interneurons in the cat. Brain Res., 151, 307-321.
3. 2 adrenergic receptor subtypes, Ann. New York Acad. Sci., 763, 1-7.
4. CALVILLO, O. & GHIGNONE, M. (1986). Presynaptic effect of clonidine on unmyelinated afferent fibres in the spinal cord of the cat. Neurosci. Lett., 64, 335.
5. DAVIES, J. & QUINLAN, J.E. (1985). Selective inhibition of responses in feline dorsal horn neurons to noxious cutaneous stimuli by tizanidine (DS-103-282) and noradrenaline: Involvement of α adrenoceptors. Neuroscience, 16, 673-682.
6. DELFS, J.M., KONG, H.Y., MESTEK, A., CHEN, Y., YU, L., REISINE, T. & CHESSELET, M.F. (1994). Expression of μ opioid receptor messenger-RNA in rat brain- and in situ hybridisation study at the single cell level. J. Comp. Neurol., 345, 46-68.
7. 2 receptors. Eur. J. Pharmacol., 333, 9-15.
8. EISENACH, J.C., DEWAN, D., ROSE, J. & ANGELO, J. (1987). Epidural clonidine produces antinociception, but not hypotension in sheep. Anaesthesiology, 66, 496-501.
9. ENGBERG, I. & RYALL, R. (1966). The inhibitory action of noradrenaline and other monoamines on spinal neurons. J. Physiol., 185, 298-322.
10. FABER, E.S.L., EVANS, R.H. & CHAMBERS, J.P. (1995). Modulation of the polysynaptic reflex of the rat hemisected spinal cord by xylazine and detomidine in vitro. Br. J. Pharmacol., 116, 311P.
11. FABER, E.S.L., CHAMBERS, J.P., BRUGGER, F. & EVANS, R.H. (1997a). Depression of A and C fibre-evoked segmental reflexes by morphine and clonidine in the in vitro spinal cord of the neonatal rat. Br. J. Pharmacol., 120, 1390-1396.
12. FABER, E.S.L., CHAMBERS, J.P. & EVANS, R.H. (1997b). Effect of dexmedetomidine on NMDA receptor-mediated synaptic transmission in the neonatal rat hemistected spinal cord preparation in vitro. Br. J. Pharmacol., 122, 36P.
13. 2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurons. Brain Res., 334, 243-254.
14. GARCIA-ARRARAS, J.E., MURAKOSHI, T., YANAGISAWA, M. & OTSUKA, M. (1986). Descending inhibition of slow spinal reflex in an in vitro preparation of the newborn rat and its possible involvement in pain control. Brain Res., 379, 188-191.
15. 2 adrenoceptor agonist in the spinal dorsal horn is due to a direct spinal action and not to activation of descending inhibition. Brain Res. Bull., 37, 581-587.
16. HAMM, D., TURCHI, P. & JOCHLE, W. (1995). Sedative and analgesic effects of detomidine and romifidine in horses. Veterinary Record, 136, 324-327.
17. 2-Adrenoceptor agonists and anaesthesia. Br. J. Anaesth., 71, 108-118.
18. 2 adrenoceptors. Ann. New York Acad. Sci., 763, 8-21.
19. 2 adrenoceptor binding to, and the substance P, enkephalin, and neurotensin content of, the cat lumbar spinal cord. Neuroscience, 21, 385-394.
20. 2 adrenoceptor subtypes to the antinociceptive action of dexmedetomidine and clonidine in rodent models of acute and chronic pain. Br. J. Pharmacol., 120, 229P.
21. IDANPAAN-HEIKKILA, J.J., KALSO, E.A. & SAPPALA, T. (1994). Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U50.488H against noxious thermal, mechanical and inflammatory stimuli. J. Pharmacol. Exp. Ther., 271, 1306-1313.
22. KAMERLING, S.G., CRAVENS, W.M.T. & BAGWELL, C.A. (1988). Objective assessment of detomidine-induced analgesia and sedation in the horse. Eur. J. Pharmacol., 151, 1-8.
23. 2-Adrenoceptors inhibit a nociceptive response in neonatal rat spinal cord. Eur. J. Pharmacol., 192, 293-300.
24. KURAISHI, Y., HIROTA, N., SATO, Y., KANEKO, S., SATOH, M. & TAKAGI, H. (1985). Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res., 359, 177-182.
25. LEIMDORFER, A. & METZNER, W.R. (1949). Analgesia and anaesthesia induced by epinephrine. Am. J. Physiol., 157, 116-121.
26. 2-adrenoceptor agonist, xylazine, in sheep. J. Vet. Pharmacol. Ther., 14, 141-144.
27. MACDONALD, E., SCHEININ, H. & SCHEININ, M. (1988). Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative. Eur. J. Pharmacol., 158, 119-127.
28. alpha-2A adrenergic receptors in the control of nociception, motor behaviour and hippocampal synthesis of noradrenahne. J. Pharmacol. Exp. Ther., 270, 958-972.
29. 2 adrenoceptors agonists in sheep. J. Vet. Pharmacol. Ther., 10, 202-209.
30. NORTH, R.A. & YOSHIMURA, M. (1984). The actions of noradrenaline on neurons of the rat substantia gelatinosa in vitro. J. Physiol., 349, 43-55.
31. 2 adrenergic agonists, and local anaesthetics in mice and rats. Anaesth. Analg., 67, 616-624.
32. 2 adrenergic mechanisms in the medetomidine-induced antinociception. Neuroscience, 44, 705-714.
33. REDDY, S.V.R., MADERDRUT, J.L. & YAKSH, T.L. (1980). Spinal cord pharmacology of adrenergic agonist-mediated antinoception. J. Pharmacol. Exp. Ther., 213, 525-533.
34. SAVOLA, M.K.T. & SAVOLA, J.-M. (1996). Alpha-2A/D adrenoceptor subtype predominates also in the neonatal rat spinal cord. Develop. Brain Res., 94, 106-108.
35. SIAREY, R.J., LONG, S.K. & EVANS, R.H. (1992). The effect of centrally acting myorelaxants on NMDA receptor-mediated synaptic transmission in the immature rat spinal cord in vitro. Br. J. Pharmacol., 107, 628-633.
36. 2 adrenoceptors. Eur. J. Pharmacol., 215, 109-117.
37. 3H]atipamezole in rat lung. Ann. New York Acad. Sci., 763, 66-77.
38. 2 Adrenoceptor modulation of nociception in rat spinal cord: location, effects and interactions with morphine. Eur. J. Pharmacol., 138, 169-177.
39. SULLIVAN, A.F., KALSO, E.A., MCQUAY, H.J. & DICKENSON, A.H. (1992). The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetised rat. Eur. J. Pharmacol. 215, 127-133.
40. VIRTANEN, R. (1986). Antinociceptive activity and mechanism of action of detomidine. J. Vet. Pharmacol. Ther., 9, 286-292.
41. 2 adrenoceptor agonist. Eur. J. Pharmacol., 150, 9-14.
42. 2 adrenoceptors by atipamezole. Arch. Int. Pharmacodyn., 297, 190-304.
43. YAKSH, T.L. (1985). Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol. Biochem. Behav., 22, 845-857.
44. 2 adrenoceptor agonists. J. Pharmacol. Exp. Ther., 272, 207-214.
45. YAKSH, T.L. & REDDY, S.V.R. (1981). Studies in the primate on the analgesic effects associated with intrathecal actions of opiates, α-adrenergic agonists and baclofen. Anaesthesiology, 54, 451-467.
46. YANAGISAWA, M., MURAKOSHI, T., TAMAI, S. & OTSUKA, M. (1985). Tail-pinch method in vitro and the effects of some antinociceptive compounds. Eur. J. Pharmacol., 106, 231-239.